Live In Play®
Updated: 12-Apr-21 08:16 ET
WIRES:  On The Wires 
  • Flagship Biosciences and Leap Therapeutics (LPTX) announced a partnership to use a clinically validated tumor expression assay utilizing RNAscope and tissue image analysis. In a poster shared this week at the American Association for Cancer Research (AACR) Annual Meeting 2021, the companies presented data on the validation of a Dickkopf-1 (DKK1) RNAscope chromogenic in situ hybridization (CISH) assay and digital image analysis solution.
  • Plus (formerly Plus.ai), a leading global self-driving truck technology company, announced today that the company has signed a Memorandum of Understanding (MOU) with IVECO, a brand of CNH Industrial N.V. (CNHI) and a pioneer in the commercialization and manufacturing of vehicles powered by alternative fuels, to jointly develop autonomous trucks that will be deployed across Europe, China, and other geographies.
  • Twist Bioscience (TWST) will exercise its option to purchase all rights to a G-coupled protein receptor (GPCR) library and its proprietary Twist Antibody Optimization (TAO) software, both developed in collaboration with Distributed Bio.
Send
Chat Icon